Canada’s Leading Research Universities

Developing talent, Driving innovation, Delivering impact.

USask VIDO-InterVac research team. (Photo: University of Saskatchewan)

Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine

Posted on

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards human clinical trials: the novel vaccine has proven highly effective in ferrets, one of the commonly used animal models for COVID-19….

https://news.usask.ca/articles/research/2020/promising-pre-clinical-results-for-usask-vido-intervac-covid-19-vaccine.php

Read More Impact Stories

Posted on

Spinal cord injury: stimulating neural plasticity to improve walking

This article is only available in French. Lésion de la moelle épinière: stimuler la plasticité des neurones pour améliorer la [...]
Read more
Posted on

Unraveling the complexity of betacoronaviruses in bats

A comprehensive study by scientists at UdeM maps the evolutionary dynamics and risks of viral emergence of diseases that could [...]
Read more
Posted on

Respiratory infections: better patient triage to relieve pressure on emergency departments

This article is available only in French. Infections respiratoires: mieux trier les patients pour soulager la pression sur les urgences [...]
Read more
View All Impact Stories